| scholarly article | Q13442814 |
| P2093 | author name string | Lu Zhang | |
| Ashok B Kulkarni | |||
| Zhi-Jun Sun | |||
| Yansong Bian | |||
| P2860 | cites work | Differential expression of microRNAs in tumors from chronically inflamed or genetic (APC(Min/+)) models of colon cancer | Q21135494 |
| MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer | Q21195215 | ||
| Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states | Q21260380 | ||
| Global cancer statistics | Q22241238 | ||
| Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma | Q24646667 | ||
| Real-time expression profiling of microRNA precursors in human cancer cell lines | Q24817136 | ||
| Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase | Q39702418 | ||
| MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor | Q39840690 | ||
| Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases | Q39855219 | ||
| Abundance of aspargynyl-hydroxylase FIH is regulated by Siah-1 under normoxic conditions | Q40012350 | ||
| Interleukin-13 receptor-targeted cancer therapy in an immunodeficient animal model of human head and neck cancer | Q43708571 | ||
| MicroRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy | Q47199545 | ||
| The rectal cancer microRNAome--microRNA expression in rectal cancer and matched normal mucosa. | Q47318149 | ||
| miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. | Q53301966 | ||
| Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma. | Q54289699 | ||
| Plasma miR-21: a potential diagnostic marker of colorectal cancer | Q84740946 | ||
| MicroRNA biogenesis and cancer | Q85172584 | ||
| Biogenesis of small RNAs in animals | Q27861013 | ||
| Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer | Q28287415 | ||
| TGFbeta in Cancer | Q28288866 | ||
| microRNA functions | Q29547393 | ||
| Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1 | Q29614651 | ||
| The mutational landscape of head and neck squamous cell carcinoma | Q29614654 | ||
| Targeting hypoxia in cancer therapy | Q29615491 | ||
| Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue | Q33331288 | ||
| Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. | Q33567879 | ||
| MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines. | Q33932172 | ||
| STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer | Q34088885 | ||
| Targeting microRNAs in cancer: rationale, strategies and challenges | Q34141089 | ||
| MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. | Q34159602 | ||
| Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells | Q34166215 | ||
| The clinical potential of microRNAs | Q34220723 | ||
| Mechanisms of control of microRNA biogenesis. | Q34310633 | ||
| Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma | Q34653637 | ||
| Maximizing mouse cancer models | Q34661270 | ||
| miR-21: a small multi-faceted RNA. | Q34931601 | ||
| Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues | Q34997758 | ||
| Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. | Q35722714 | ||
| Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer | Q36110374 | ||
| MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion | Q36215845 | ||
| Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model. | Q36295853 | ||
| miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue | Q37157776 | ||
| MicroRNA profiling and head and neck cancer | Q37208449 | ||
| Hypoxia signalling through mTOR and the unfolded protein response in cancer | Q37290935 | ||
| Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway. | Q37379223 | ||
| MicroRNAs: novel regulators in the hallmarks of human cancer | Q37493501 | ||
| TGFβ signaling in head and neck squamous cell carcinoma | Q37777022 | ||
| MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer | Q37783459 | ||
| microRNAs: Master Regulators as Potential Therapeutics in Cancer | Q37784515 | ||
| The molecular biology of head and neck cancer | Q37821229 | ||
| Hypoxia-inducible factors in OSCC. | Q37940756 | ||
| Curcumin Dually Inhibits Both Mammalian Target of Rapamycin and Nuclear Factor-κB Pathways through a Crossed Phosphatidylinositol 3-Kinase/Akt/IκB Kinase Complex Signaling Axis in Adenoid Cystic Carcinoma | Q39642225 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| microRNA | Q310899 | ||
| P304 | page(s) | 230-238 | |
| P577 | publication date | 2013-01-20 | |
| P1433 | published in | Cancer Letters | Q326372 |
| P1476 | title | MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma | |
| P478 | volume | 331 |
| Q35832228 | Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transition |
| Q88312688 | Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma |
| Q39627356 | B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma |
| Q26765222 | C4.4A as a biomarker of head and neck squamous cell carcinoma and correlated with epithelial mesenchymal transition |
| Q36089907 | Dickkopf‑related protein 1 induces angiogenesis by upregulating vascular endothelial growth factor in the synovial fibroblasts of patients with temporomandibular joint disorders |
| Q49361097 | Down-regulation of microRNA-135 promotes sensitivity of non-small cell lung cancer to gefitinib by targeting TRIM16. |
| Q36261352 | Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1. |
| Q36346978 | Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma |
| Q28543724 | Epidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor-1α and Notch1 in head neck squamous cell carcinoma |
| Q34683987 | Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. |
| Q38263349 | Genetic modification of hypoxia signaling in animal models and its effect on cancer |
| Q36998335 | Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma |
| Q48159682 | Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer. |
| Q35835245 | Inhibition of STAT3 reduces proliferation and invasion in salivary gland adenoid cystic carcinoma. |
| Q37215789 | Inhibition of mTOR reduces anal carcinogenesis in transgenic mouse model |
| Q35499428 | Inhibition of survivin reduces HIF-1α, TGF-β1 and TFE3 in salivary adenoid cystic carcinoma |
| Q41997200 | LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma. |
| Q90701331 | Ligustrazine promoted hypoxia-treated cell growth by upregulation of miR-135b in human umbilical vein endothelial cells |
| Q38938528 | MiR-135b promotes proliferation and invasion of osteosarcoma cells via targeting FOXO1. |
| Q64953093 | MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma. |
| Q28546971 | MicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell Carcinoma |
| Q38155170 | MicroRNA-135b and Its Circuitry Networks as Potential Therapeutic Targets in Colon Cancer |
| Q41136545 | MicroRNA-135b regulates ERα, AR and HIF1AN and affects breast and prostate cancer cell growth |
| Q35757995 | MicroRNA-135b regulates apoptosis and chemoresistance in colorectal cancer by targeting large tumor suppressor kinase 2. |
| Q39042824 | MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer |
| Q35273709 | MicroRNA-135b, a HSF1 target, promotes tumor invasion and metastasis by regulating RECK and EVI5 in hepatocellular carcinoma |
| Q48154030 | MicroRNAs expression profile in solid and unicystic ameloblastomas |
| Q64243138 | Micrornas at the Interface between Osteogenesis and Angiogenesis as Targets for Bone Regeneration |
| Q28080346 | Noncoding RNAs in Tumor Epithelial-to-Mesenchymal Transition |
| Q35137825 | Notch signaling induces epithelial-mesenchymal transition to promote invasion and metastasis in adenoid cystic carcinoma |
| Q88917727 | Over-expression of IQGAP1 indicates poor prognosis in head and neck squamous cell carcinoma |
| Q41940467 | Overexpression of miR-135b-5p promotes unfavorable clinical characteristics and poor prognosis via the repression of SFRP4 in pancreatic cancer |
| Q36561681 | PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma |
| Q47152233 | Peripheral lung adenocarcinomas harboring epithelial growth factor receptor mutations with microRNA-135b overexpression are more likely to invade visceral pleura |
| Q93374126 | Profiling microRNA expression in Atlantic killifish (Fundulus heteroclitus) gill and responses to arsenic and hyperosmotic stress |
| Q37283359 | Prognostic value of decreased microRNA-133a in solid cancers: a meta-analysis |
| Q37706535 | Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma |
| Q57468226 | Reciprocal regulations between miRNAs and HIF-1α in human cancers |
| Q51361835 | SATB1 promotes tumor metastasis and invasiveness in oral squamous cell carcinoma. |
| Q36561640 | STAT3 blockade enhances the efficacy of conventional chemotherapeutic agents by eradicating head neck stemloid cancer cell |
| Q37432727 | Smoking and microRNA dysregulation: a cancerous combination |
| Q48199906 | TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma. |
| Q37012605 | Targeting STAT3 signaling reduces immunosuppressive myeloid cells in head and neck squamous cell carcinoma |
| Q89514252 | The interplay between HIF-1α and noncoding RNAs in cancer |
| Q36545707 | miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal |
| Q39038804 | miR-193b/365a cluster controls progression of epidermal squamous cell carcinoma |
| Q48164135 | γ-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma. |
Search more.